We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 127.50 | 120.00 | 135.00 | 130.00 | 127.50 | 127.50 | 22,023 | 15:50:53 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -3.05 | 87.7M |
From Apr 2019 to Apr 2024
LONDON--Finnish drug group Faron Pharmaceuticals Ltd (FARN.LN) Wednesday said it has appointed two new non-executive directors.
Gregory Brown has more than 35 years of experience in healthcare and investment, having most recently founded HealthCare Royalty Partners, a health-focused private asset manager investing in bio-pharmaceutical and medical products, where he is Vice-Chairman.
John Poulos has spent 38 years working for drug groups AbbVie Inc (ABBV) and Abbott Pharmaceuticals.
-Write to Philip Waller at philip.waller@wsj.com
(END) Dow Jones Newswires
April 19, 2017 03:16 ET (07:16 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Faron Pharmaceuticals Oy Chart |
1 Month Faron Pharmaceuticals Oy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
